Prebiotic + Probiotic Supplement for Vaginal Infections

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Happy V

Trial Summary

What is the purpose of this trial?

This virtual randomized controlled trial evaluates the efficacy of a prebiotic and probiotic supplement in providing relief from symptoms associated with bacterial vaginosis and yeast infections. Participants will be randomized into three groups-test product, active placebo, and excipient placebo-and will take two capsules daily for 30 days. The study will assess the effects on vaginal microbiome, symptoms of bacterial vaginosis and yeast infections, and overall vaginal health.

Research Team

Eligibility Criteria

This trial is for individuals experiencing symptoms of bacterial vaginosis or yeast infections. Participants will be taking two capsules daily for a month and must have access to the internet as it's a virtual study.

Inclusion Criteria

I am a woman aged 25 or older.

I agree not to use any vaginal health products during the study.

I experience bloating, gas, or other digestive discomfort.

See 3 more

Exclusion Criteria

I have not started any new vaginal health medications or supplements in the last 3 months.

Unwilling to follow the study protocol

Anyone with known severe allergic reactions that require the use of an Epi-Pen, or any known allergies to any of the product ingredients

See 4 more

Treatment Details

Interventions

Prebiotic + Probiotic Supplement (Probiotic)

Trial OverviewThe study tests if a prebiotic and probiotic supplement can relieve symptoms associated with vaginal infections. It compares this test product to an active placebo and an excipient placebo in a randomized, controlled setup.

Participant Groups

3Treatment groups

Experimental Treatment

Placebo Group

Group I: Test Product GroupExperimental Treatment1 Intervention

Participants in this group will receive the test product, a prebiotic and probiotic supplement.

Group II: Active Placebo GroupPlacebo Group1 Intervention

Participants in this group will receive an active placebo.

Group III: Excipient Placebo GroupPlacebo Group1 Intervention

Participants in this group will receive an excipient placebo.